Sector › Medicine
Press Releases
Gain Therapeutics Doses First Participant in Phase 1b Clinical Trial of GT-02287 in Parkinson's Disease
Gain Therapeutics
Mar 14, 2025 19:54 HKT/SGT
World's Most Sleep-Deprived Nation Has a Gender Crisis: Why Singaporean Women Bear the Heaviest Burden
LAC Global
Mar 10, 2025 13:00 HKT/SGT
CEPI funds Nagasaki University to develop innovative vaccines using Nanoball platform and NEC's AI
NEC Corporation
Mar 10, 2025 11:10 HKT/SGT
OrbusNeich Achieves Fourth Consecutive Year of Revenue Growth with Record High Revenue of US$164.1 Million and Net Profit of US$39.7 Million
OrbusNeich Medical Group Holdings Limited
Mar 07, 2025 18:40 HKT/SGT
業聚醫療連續四年實現收入增長 達1.64億美元創新高 純利達3,970萬美元 建議派發末期股息每股10港仙
OrbusNeich Medical Group Holdings Limited
Mar 07, 2025 18:28 HKT/SGT
业聚医疗连续四年实现收入增长 达1.64亿美元创新高 纯利达3,970万美元 建议派发末期股息每股10港仙
OrbusNeich Medical Group Holdings Limited
Mar 07, 2025 18:10 HKT/SGT
Register Now: analytica Vietnam's Largest Edition & Must-See Innovations!
MMI Asia Pte Ltd (MMI)
Mar 06, 2025 07:32 HKT/SGT
Eisai: Update on the Co-Promotion of the Oral Antifungal Agent Nailin Capsules 100mg in Japan
Eisai
Mar 05, 2025 08:09 HKT/SGT
Micreos Pharmaceuticals 與生物製劑 CDMO Northway Biotech 合作推動其工程化內溶素療法製造計畫
Northway Biotech
Mar 04, 2025 23:00 HKT/SGT
Micreos Pharmaceuticals Partners With Biologics CDMO Northway Biotech for Its Engineered Endolysin Therapeutic Manufacturing Program
Northway Biotech
Mar 04, 2025 20:00 HKT/SGT
Media Alert: Say Goodbye to Brain Fog and Digestive Woes: Recharge for the New Year with LAC
LAC Global
Mar 04, 2025 18:00 HKT/SGT
重磅發佈 - 君聖泰醫藥在JAMA Network Open發表熊去氧膽小檗鹼治療2型糖尿病的臨床2期研究數據 療效顯著 多重代謝獲益 市場前景廣闊
HighTide Therapeutics Inc.
Mar 04, 2025 16:48 HKT/SGT
Eisai Receives Regulatory Review Outcome for Lecanemab as a Treatment for Early Alzheimer's Disease in Australia
Eisai
Mar 04, 2025 16:22 HKT/SGT
重磅发布 - 君圣泰医药在JAMA Network Open发表熊去氧胆小檗碱治疗2型糖尿病的临床2期研究数据 疗效显著 多重代谢获益 市场前景广阔
HighTide Therapeutics Inc.
Mar 04, 2025 12:32 HKT/SGT
HighTide Therapeutics Announces Publication of Phase 2 Study of Berberine Ursodeoxycholate for the Treatment of Type 2 Diabetes Mellitus in JAMA Network Open
HighTide Therapeutics Inc.
Mar 04, 2025 12:26 HKT/SGT